Surgery vs. Casting for Displaced Articular Radius Fractures in Elderly (DART)

January 16, 2023 updated by: JointResearch

The Effectiveness of Surgery Versus Casting for Elderly Patients With Displaced Distal Intra-Articular Radius Fractures: A Randomized Controlled Trial

Objective: to compare the functional outcome after open reduction and internal fixation with non-operative cast treatment for elderly patients with displaced intra-articular distal radius fractures.

Study Overview

Detailed Description

Rationale: there is no consensus about the optimal treatment of displaced intra-articular distal radius fractures in elderly patients. To ensure optimal functional outcome there is a tendency to operate. However, there is no evidence that supports the surgical treatment of patients aged 65 years or older and in the absence of clinical trials it stays unclear how elderly patients with intra-articular fractures should be treated.

Study design: multi-center randomized controlled trial with a non-inferiority design. Economic evaluation alongside a randomized controlled multi-center trial.

Study population: all consecutive patients aged between 65 years and older with displaced intra-articular (AO Type C) distal radius fractures, with a not acceptable reduction within 3 weeks following trauma.

Intervention: patients will be randomized between open reduction and internal fixation (intervention group) and plaster immobilization (control group).

Main study parameters: the primary outcome will be evaluated after 1 year with the Patient-Rated Wrist Evaluation score (PRWE). Secondary outcomes comprise other patient reported outcome measures (PROM) including the Disability of the Arm, Shoulder and Hand (DASH), Quality of life (EQ-5D) and Pain Catastrophizing Scale (PCS). Further outcome measurements comprise a costs evaluation questionnaire, range of motion (ROM), grip strength, radiographic parameters and Complications.

Study Type

Interventional

Enrollment (Actual)

138

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Noord Holland
      • Amsterdam, Noord Holland, Netherlands, 1090 hm
        • Onze Lieve Vrouwe Gasthuis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • > 65 years at time of trauma
  • Intra-articular distal radius fracture (AO type C*)
  • One or more of the following fracture characteristics within 3 weeks post-trauma (including secondary dislocation):

    ≤15° inclination <5 mm radial length >15° dorsal tilt >20° volar tilt intra-articular gap or step-off >2 mm

  • < 3 weeks post trauma
  • Living independent
  • Fit for surgery
  • Mentally competent
  • Dutch fluency and literacy
  • Informed consent

Exclusion Criteria:

  • Open fractures
  • Neurovascular damage
  • Multiple-trauma patients (ISS >16)
  • Other fractures in the injured extremity other than ulnar styloid process fractures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Open reduction internal fixation
Surgical open reduction internal fixation (ORIF)
Either volar of dorsal plating or both
Other Names:
  • ORIF Open Reduction Internal Fixation
Active Comparator: Plaster immobilization
Standard local hospital protocol for cast treatment
Hospitals may use their preferred protocol
Other Names:
  • Plaster

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PRWE
Time Frame: 12 months
Patient-Rated Wrist Evaluation score
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DASH
Time Frame: 12 months
Disability of the Arm, Shoulder and Hand
12 months
EQ/5D
Time Frame: 12 months
Quality of life
12 months
PCS
Time Frame: 12 months
Pain Catastrophizing Scale
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
ROM
Time Frame: 12 months
range of motion
12 months
grip strength
Time Frame: 12 months
grip strength of both wrists
12 months
Radiographic parameters
Time Frame: 6 months
Radial inclination, volar/dorsal tilt, ulnar variance, gap, step off and radial length
6 months
Complications
Time Frame: 12 months
Complications of either treatment arm
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Rudolf W Poolman, Prof. MD PhD, OLVG, Amsterdam, the Netherlands

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

November 1, 2022

Study Completion (Actual)

November 1, 2022

Study Registration Dates

First Submitted

December 22, 2016

First Submitted That Met QC Criteria

January 2, 2017

First Posted (Estimate)

January 4, 2017

Study Record Updates

Last Update Posted (Actual)

January 18, 2023

Last Update Submitted That Met QC Criteria

January 16, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • NL56858.100.16

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Radius Distal Fracture

Clinical Trials on Surgery (Open Reduction Internal Fixation)

3
Subscribe